Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Heaphy

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Pathology|December 18, 2020
Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomesHeidi Hempel Sullivan, Janielle P Maynard, Christopher M Heaphy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 28, 2010
Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasiasSeung-Mo Hong, Christopher M Heaphy, Chanjuan Shi, et al.
Frontiers in Medicine|June 19, 2024
Longer prostate stromal cell telomere length is associated with increased risk of death from other cancersJoakin O Mori, Elizabeth A Platz, Jiayun Lu, et al.
Brain Pathology (Zurich, Switzerland)|August 30, 2012
Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomasDoreen N Nguyen, Christopher M Heaphy, Roeland F de Wilde, et al.
Schizophrenia Bulletin|March 13, 2009
Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosisEmilio Fernandez-Egea, Miguel Bernardo, Christopher M Heaphy, et al.
The Prostate|August 6, 2010
Organ-wide telomeric status in diseased and disease-free prostatic tissuesChristopher M Heaphy, Trisha M Fleet, Eric G Treat, et al.
Diagnostic Cytopathology|December 18, 2019
Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspirationWenzel M Hackeng, Folkert H M Morsink, Leon M G Moons, et al.
Clinical Chemistry|December 7, 2018
Adding the Team into T1 Translational Research: A Case Study of Multidisciplinary Team Science in the Evaluation of Biomarkers of Prostate Cancer Risk and PrognosisMichael T Marrone, Corinne E Joshu, Sarah B Peskoe, et al.
Cancer Causes & Control : CCC|July 8, 2018
Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlationsKari A Weber, Christopher M Heaphy, Corinne E Joshu, et al.
Journal of the American College of Surgeons|March 25, 2014
Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastasesEpameinondas Dogeas, Georgios Karagkounis, Christopher M Heaphy, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Pathology|December 18, 2020
Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomesHeidi Hempel Sullivan, Janielle P Maynard, Christopher M Heaphy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 28, 2010
Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasiasSeung-Mo Hong, Christopher M Heaphy, Chanjuan Shi, et al.
Frontiers in Medicine|June 19, 2024
Longer prostate stromal cell telomere length is associated with increased risk of death from other cancersJoakin O Mori, Elizabeth A Platz, Jiayun Lu, et al.
Brain Pathology (Zurich, Switzerland)|August 30, 2012
Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomasDoreen N Nguyen, Christopher M Heaphy, Roeland F de Wilde, et al.
Schizophrenia Bulletin|March 13, 2009
Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosisEmilio Fernandez-Egea, Miguel Bernardo, Christopher M Heaphy, et al.
The Prostate|August 6, 2010
Organ-wide telomeric status in diseased and disease-free prostatic tissuesChristopher M Heaphy, Trisha M Fleet, Eric G Treat, et al.
Diagnostic Cytopathology|December 18, 2019
Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspirationWenzel M Hackeng, Folkert H M Morsink, Leon M G Moons, et al.
Clinical Chemistry|December 7, 2018
Adding the Team into T1 Translational Research: A Case Study of Multidisciplinary Team Science in the Evaluation of Biomarkers of Prostate Cancer Risk and PrognosisMichael T Marrone, Corinne E Joshu, Sarah B Peskoe, et al.
Cancer Causes & Control : CCC|July 8, 2018
Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlationsKari A Weber, Christopher M Heaphy, Corinne E Joshu, et al.
Journal of the American College of Surgeons|March 25, 2014
Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastasesEpameinondas Dogeas, Georgios Karagkounis, Christopher M Heaphy, et al.
Pageof 12